Corrigendum to "Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)"
对“多替拉韦联合拉米夫定用于维持对拉米夫定有或无既往耐药史的成人 HIV 病毒抑制：一项非随机试点临床试验 (ART-PRO) 的 48 周结果”的更正
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2023.104486
De Miguel, Rosa; Rial-Crestelo, David; Dominguez-Dominguez, Lourdes; Montejano, Rocío; Esteban-Cantos, Andrés; Aranguren-Rivas, Paula; Stella-Ascariz, Natalia; Bisbal, Otilia; Bermejo-Plaza, Laura; Garcia-Alvarez, Mónica; Alejos, Belén; Hernando, Asunción; Santacreu-Guerrero, Mireia; Cadiñanos, Julen; Mayoral, Mario; Castro, Juan Miguel; Moreno, Victoria; Martin-Carbonero, Luz; Delgado, Rafael; Rubio, Rafael; Pulido, Federico; Arribas, José Ramón
